inflammatory bowel disease
ProciseDx Enters Markets for Inflammation, Medication Monitoring With Five-Minute POC Instrument
Premium
The firm has developed an instrument that uses fingerstick blood or stool samples to enable quantitative results for the management of conditions caused by inflammation.
Norwegian Firm Genetic Analysis Awarded $1.9M to Develop Microbiome Test for IBD Treatment
Genetic Analysis said its platform is based on a multiplex approach for the simultaneous analysis of a large number of bacteria in one reaction.
A graduate of the Y Combinator startup accelerator, the company combines shallow sequencing and data from a diverse population to predict treatment response.
Prometheus Biosciences Prices Upsized $190M IPO
The company is focused on developing and commercializing therapeutic and companion diagnostic products to treat inflammatory bowel disease.
KSL Biomedical to Commercialize PredictImmune IBD Test in North America
Under the deal, KSL will commercialize and facilitate orders of the PredictSURE IBD test throughout North America and will also process all samples through its laboratory, KSL Diagnostics.